Thousand Oaks, CA, United States of America

Arlen Read Thomason

This inventor holds 20 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Fibroblast Growth Factors. Top assignee: Amgen Inc.. Active years: 1992-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arlen Read Thomason. Retrieved from https://idiyas.com/inventor/arlen-read-thomason

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 55.0


Average Co-Inventor Count = 1.8

ph-index = 12

Forward Citations = 465(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (1992 - 2011)
  • Walterville, OR (US) (2010 - 2011)

Company Filing History:


Years Active: 1992-2011

Loading Chart...
Loading Chart...
Areas of Expertise:
Fibroblast Growth Factor
Polypeptides
Obesity Treatment
Diabetes Therapy
Antibodies
Nucleic Acids
Recombinant Host Cells
Biologically Active Polypeptides
Platelet-Derived Growth Factor
Fusion Dimers
Hybrid Receptor Molecules
Purification Methods
20 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Arlen Read Thomason

Introduction: Arlen Read Thomason, based in Thousand Oaks, California, is a prominent inventor renowned for his contributions in the field of biotechnology. With an impressive portfolio of 20 patents, his work focuses on novel methods for medical treatments, particularly in addressing obesity and related conditions.

Latest Patents: Among his latest innovations are two pivotal patents that reflect his expertise in fibroblast growth factor-like polypeptides. The first patent outlines methods for treating obesity using these polypeptides, which offer new avenues for reducing body weight in mammals. The second patent introduces novel fibroblast growth factor-like polypeptides and provides various applications, including vectors, host cells, and antibodies for their production. This invention also emphasizes the potential for diagnosing and treating diseases associated with fibroblast growth factors.

Career Highlights: Arlen Read Thomason serves as a vital member of Amgen Inc., a leader in biotechnology dedicated to making a difference in patients' lives through innovative therapies. Over the years, he has built a remarkable career by utilizing his extensive knowledge and skills to develop groundbreaking inventions that have the potential to enhance health outcomes.

Collaborations: Throughout his career, Thomason has collaborated with esteemed colleagues, including Benxian Liu and Dimitry Michael Danilenko. These partnerships have led to the advancement of various projects and patents, further establishing his reputation as a key innovator in the field.

Conclusion: Arlen Read Thomason's dedication to innovation and his significant contributions to biotechnology underscore his important role in the scientific community. His work not only exemplifies the spirit of invention but also holds promise for future developments in medical treatments, demonstrating the impactful journey of an inventor committed to improving health and well-being.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…